Condition: Osteoporosis in Post-menopausal Women · Sponsor: Odense University Hospital
The goal of this clinical trial is to study the effects of discontinuation of Alendronate treatment for three years. The participants are postmenopausal women with osteoporosis, who have had a treatment period without fractures. The study will answer: * What is the rate of fragility fractures during the study? The hypothesis is that discontinuation of Alendronate after a fracture-free period does not raise the 3-year fracture risk. * Are there predictors of significant bone loss after discontinuation of Alendronate? The hypothesis is that clinical, biochemical, cellular, or molecular characteristics can predict bone loss. Researchers will compare the outcomes of discontinuation of Alendronate with continuing treatment. Participants will be randomly assigned to a group. Participants will: * Either take alendronate once weekly for three years OR discontinue their treatment * Visit the clinic at 6 and 18 months for blood samples * Visit the clinic at the start of the study and after 1, 2, and 3 years for bone scans and blood samples.
This description comes directly from the study's public registry record.
Pernille Hermann, MD, PhD. · +4523602366 · pernille.herman@rsyd.dk
Lars Folkestad, MD, PhD. · +4529648537 · lars.folkestad@rsyd.dk
Always discuss trial participation with your own doctor first.
| Aalborg University Hospital | Aalborg, Denmark | Not Yet Recruiting |
| Bispebjerg Hospital | Copenhagen, Denmark | Not Yet Recruiting |
| Esbjerg Og Grindsted Sygehus | Esbjerg, Denmark | Not Yet Recruiting |
| Copenhagen University Hospital (Herlev) | Herlev, Denmark | Not Yet Recruiting |
| Nordsjaellands Hospital (Hillerød) | Hillerød, Denmark | Not Yet Recruiting |
| Hvidovre Hospital | Hvidovre, Denmark | Not Yet Recruiting |
| Odense University Hospital | Odense, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06864130